Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05220332 · ClinicalTrials.gov registry record · NA
Church-based Intervention to Improve Blood Pressure in African Americans
A NA study of Hypertension, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 312
- Enrollment target
- 1
- Study location
NCT05220332: Recruiting NA study of Hypertension, sponsored by Rush University Medical Center.
NCT05220332 is a NA study of Hypertension that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 312 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05220332, a NA study of Hypertension, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 312 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 12-month behavioral cluster-randomized trial testing a church-based intervention to reduce blood pressure in African Americans with uncontrolled blood pressure.
Primary Outcome
The primary outcome is systolic blood pressure at 6 months post start of the intervention. The Omron digital blood pressure monitor will be utilized to measure blood pressure (Omron Healthcare, Inc., Lake Forest, IL). The participant will sit quietly for \>5 minutes, 3 readings will be taken 1-2 minutes apart while seated, and an average of the last 2 readings will be taken to evaluate blood pressure.
Conditions Studied
Interventions
- BEHAVIORAL Heart to Heart
- BEHAVIORAL Money Smart
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT05220332 shows while recruiting
NCT05220332 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Heart to Heart is the first listed.
NCT05220332 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05220332 about?
NCT05220332 is a clinical study titled "Church-based Intervention to Improve Blood Pressure in African Americans". This is a 12-month behavioral cluster-randomized trial testing a church-based intervention to reduce blood pressure in African Americans with uncontrolled blood pressure.
What is the current status of trial NCT05220332?
This trial is currently recruiting. It is a NA study. The enrollment target is 312 participants. The study started on 2022-03-15. Estimated completion is 2026-07.
What conditions does trial NCT05220332 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT05220332?
The interventions under investigation include: Heart to Heart (BEHAVIORAL), Money Smart (BEHAVIORAL).
Who is sponsoring clinical trial NCT05220332?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05220332 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05220332's enrollment target sits among peer trials
312 163rd of 470 higher than 308 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
- NCT05520593 · 312 participants · NA
Preoperative Oral Hydration in the Ambulatory Arthroplasty Population
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI